| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $52.0M | +71.4% |
| SG&A Expense | $18.6M | +46.7% |
| Pre-tax Income | -$35.8M | +11.3% |
| Income Tax | $431K | — |
| Net Income | -$36.2M | +10.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.5M | +345.6% |
| Short-term Investments | $119.6M | +157.3% |
| Current Assets | $143.7M | +156.1% |
| Total Assets | $177.4M | +99.2% |
| Current Liabilities | $11.6M | +197.2% |
| Total Liabilities | $59.3M | +949.5% |
| Stockholders' Equity | $62.4M | -25.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.3M | -19.6% |
| Investing Cash Flow | -$70.3M | -55.3% |
| Financing Cash Flow | $133.5M | +304.4% |